Health News
59 NJ biopharma companies could be negatively impacted by Inflation Reduction Act drug provision
A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said a visiting professor at Rutgers University.
NJ Health Care Reform Group: Government price setting an obstacle to ‘research and cures’
The executive director of Patients Come First - New Jersey (PCF-NJ) said that government price setting in health care will negatively impact “access to research and cures.”